Job Title: FDA Cellular Therapeutics Fellowship
Job Number: 78456
Location: Silver Spring, US
Job Description:
A research opportunity is available immediately in the Division of Cell Therapy (DCT2), within the Office of Cellular Therapy and Human Tissue (OCTHT) at the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA) located in Silver Spring, Maryland.
The Center for Biologics Evaluation and Research (CBER) is one Center within the Food and Drug Administration, an Agency within the United States Government’s Department of Health and Human Services. CBER’s mission is to protect and enhance the public health through the regulation of biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies.
Research Project: CBER’s mission is to ensure the safety, purity, potency, and effectiveness of biological products including vaccines, blood and blood products, and cells, tissues, and gene therapies for the prevention, diagnosis, and treatment of human diseases, conditions, or injury. This appointment’s research is focused on understanding the advanced manufacturing of CRISPR/Cas9-edited cellular therapeutics. Using the CRISPR/Cas9 genome editing tool, we are developing methods for derivation and expansion of various cell therapy products through cellular reprogramming.
Application Deadline: 2024-10-31
#J-18808-Ljbffr
